BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 37641591)

  • 1. Nature-inspired nanocarriers for improving drug therapy of atherosclerosis.
    Ji W; Zhang Y; Deng Y; Li C; Kankala RK; Chen A
    Regen Biomater; 2023; 10():rbad069. PubMed ID: 37641591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bio-Inspired Nanocarriers Derived from Stem Cells and Their Extracellular Vesicles for Targeted Drug Delivery.
    Abudurexiti M; Zhao Y; Wang X; Han L; Liu T; Wang C; Yuan Z
    Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
    Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
    J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unleashing the biomimetic targeting potential of platelet-derived nanocarriers on atherosclerosis.
    Jan N; Bostanudin MF; Moutraji SA; Kremesh S; Kamal Z; Hanif MF
    Colloids Surf B Biointerfaces; 2024 Aug; 240():113979. PubMed ID: 38823339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimuli-responsive and biomimetic delivery systems for sepsis and related complications.
    Ismail EA; Devnarain N; Govender T; Omolo CA
    J Control Release; 2022 Dec; 352():1048-1070. PubMed ID: 36372385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocarriers surface engineered with cell membranes for cancer targeted chemotherapy.
    Lei W; Yang C; Wu Y; Ru G; He X; Tong X; Wang S
    J Nanobiotechnology; 2022 Jan; 20(1):45. PubMed ID: 35062958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimuli-responsive chitosan-based nanocarriers for cancer therapy.
    Fathi M; Sahandi Zangabad P; Majidi S; Barar J; Erfan-Niya H; Omidi Y
    Bioimpacts; 2017; 7(4):269-277. PubMed ID: 29435435
    [No Abstract]   [Full Text] [Related]  

  • 8. Improving the efficiency of natural antioxidant compounds via different nanocarriers.
    Maqsoudlou A; Assadpour E; Mohebodini H; Jafari SM
    Adv Colloid Interface Sci; 2020 Apr; 278():102122. PubMed ID: 32097732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimuli-Responsive Gene Delivery Nanocarriers for Cancer Therapy.
    Zhang Q; Kuang G; Li W; Wang J; Ren H; Zhao Y
    Nanomicro Lett; 2023 Feb; 15(1):44. PubMed ID: 36752939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Internal stimuli-responsive nanocarriers for drug delivery: Design strategies and applications.
    Liu M; Du H; Zhang W; Zhai G
    Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():1267-1280. PubMed ID: 27987683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions.
    Moradi Kashkooli F; Jakhmola A; Hornsby TK; Tavakkoli JJ; Kolios MC
    J Control Release; 2023 Mar; 355():552-578. PubMed ID: 36773959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review.
    Kanamala M; Wilson WR; Yang M; Palmer BD; Wu Z
    Biomaterials; 2016 Apr; 85():152-67. PubMed ID: 26871891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Microenvironment Sensitive Nanocarriers for Bioimaging and Therapeutics.
    Park H; Saravanakumar G; Kim J; Lim J; Kim WJ
    Adv Healthc Mater; 2021 Mar; 10(5):e2000834. PubMed ID: 33073497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
    Yang Y; Zhang M; Song H; Yu C
    Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet Membrane-Coated Nanocarriers Targeting Plaques to Deliver Anti-CD47 Antibody for Atherosclerotic Therapy.
    Chen L; Zhou Z; Hu C; Maitz MF; Yang L; Luo R; Wang Y
    Research (Wash D C); 2022; 2022():9845459. PubMed ID: 35118420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ-restricted delivery through stimuli-responsive nanocarriers for lung cancer therapy.
    Dinakar YH; Karole A; Parvez S; Jain V; Mudavath SL
    Life Sci; 2022 Dec; 310():121133. PubMed ID: 36306866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme responsive drug delivery systems in cancer treatment.
    Shahriari M; Zahiri M; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    J Control Release; 2019 Aug; 308():172-189. PubMed ID: 31295542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades.
    Devnarain N; Osman N; Fasiku VO; Makhathini S; Salih M; Ibrahim UH; Govender T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1664. PubMed ID: 32808486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimuli-responsive image-guided nanocarriers as smart drug delivery platforms.
    Chen X; Lei S; Lin J; Huang P
    Expert Opin Drug Deliv; 2022 Nov; 19(11):1487-1504. PubMed ID: 36214740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimuli-responsive Polymeric Nanosystems for Therapeutic Applications.
    Handa M; Singh A; Flora SJS; Shukla R
    Curr Pharm Des; 2022; 28(11):910-921. PubMed ID: 34879797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.